|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
537
|
Thu, 8/6/09, 8:30 AM - 10:20 AM | CC-201 |
| Pharmacokinetic and Pharmacodynamic Modeling - Invited - Papers | ||
|
Biopharmaceutical Section, Biometrics Section |
||
| Organizer(s): Alan H. Hartford, Merck & Co., Inc. | ||
| Chair(s): Alan H. Hartford, Merck & Co., Inc. | ||
| 8:35 AM |
A Model-Based Framework for Quantitative Decisionmaking in Drug Development —  Kenneth G. Kowalski, Ann Arbor Pharmacometrics Group; Jonathan L. French, Pfizer Inc.; Mike K. Smith, Pfizer Inc.; Matthew M. Hutmacher, Ann Arbor Pharmacometrics Group
|
|
| 9:00 AM |
Leveraging Pharmacokinetic (PK) and Pharmacodynamic (PD) Knowledge in Early Clinical Drug Development — Ene I. Ette, Anoixis Corporation
|
|
| 9:25 AM |
Computational Methods for Nonlinear Mixed Models — Douglas M. Bates, University of Wisconsin-Madison
|
|
| 9:50 AM |
Leveraging Exposure Response Information for Efficient Drug Development: Impact of Pharmacometrics — Pravin R. Jadhav, FDA
|
|
| 10:15 AM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |